Health

ClinOne Supports 100+ Active Clinical Trials with 100% On-Time Delivery as Company Welcomes New CEO, Executives, and Partners in First Half 2022

Leave a comment


News Image

We’re on a mission to deliver Adaptive Experience solutions to truly support the clinical trial journey. We have a great team in place, we listen to customers and partners, and we’re developing world-class solutions that make a difference for clinical trial participants – ClinOne CEO Andrea Valente


BOSTON (PRWEB)

ClinOne, the leading provider of Adaptive Experiences for clinical trial participants, surpassed a significant milestone in its growth as one of the industry’s most watched companies by supporting more than 100 active trials in the first half of 2022 while achieving 100% on-time delivery and welcoming its new CEO, executives, and partners.

ClinOne provides Adaptive Experiences to all participants in clinical trials to improve retention, compliance, and conduct efficiency. The company’s true single platform features proven solutions for Consent Management, HCP Trial Awareness, Patient Ride, Medication Adherence, TeleVisits, and more.

In the first half of 2022 alone, ClinOne…


  • Surpassed 100+ active clinical trials in more than 60 languages and 55 countries

  • Named industry expert Andrea Valente, former COO of Medable, as Chief Executive Officer and added industry-seasoned executives to lead Product, HR, and Finance

  • Announced a strategic partnership with uMotif to combine the best available eCOA/ePRO and eConsent solutions with a single unified experience

  • Achieved 100% on-time delivery while managing the industry’s fastest deployment timelines (~2-6 weeks)

  • Further enhanced its industry-leading API by adding webhooks for seamless integrations and interoperability with other clinical systems

  • Unveiled its new corporate brand and website to highlight customer successes

  • Simplified complex trials with 50%+ new study starts in Oncology, CNS, and Rare Disease

Meanwhile, ClinOne has helped patients, caregivers, sites, and study teams succeed with…

  • More than 1,200 patient rides in a single trial for patients who otherwise might have missed critical site visits, dropped from the study, or not enrolled to begin with

  • Over 1,100 medication reminders per month, playing a pivotal role to keep patients on track with their treatments and avoid thousands of potential missed doses

  • 2.1 million connections with our curated network of HCPs, raising their awareness of local clinical trial opportunities and adding new options for patient care

“If you haven’t connected with ClinOne lately, it might be worth it to see what we’re building,” said CEO Andrea Valente (LinkedIn). “We are on a mission to deliver Adaptive Experience solutions which truly support the clinical trial journey. We have a great team in place, we focus on listening to what our customers and partners tell us, and we are absolutely committed to developing world-class solutions that make a real difference for all participants in clinical trials – meaning patients, caregivers, sites, and study teams. I’ve been on that mission my entire career and am so optimistic and excited about the possibilities here at ClinOne.”

In an era of industry confusion over new technologies, terms, and company claims that blend together, ClinOne’s strategy is to develop best-in-class solutions for specific customer needs and develop true partnerships that provide additional value in a single unified user experience.

“ClinOne is unique because rather than trying to provide a little bit of everything, we are focused on what we do best with solutions that add real value – a message that is clearly resonating with our customers,” said Kristopher Sarajian (LinkedIn), VP of Marketing. “At a time when many are confused by an industry landscape that promises many things, we have clearly defined and deep technology expertise in core solutions that are reliable, rapidly implemented, cost-accessible, and easily integrated at scale – regardless of whether your trial design is traditional, decentralized, or hybrid. It’s been a great start to 2022 and I look forward to even more success for all the patients, caregivers, and site staff who use ClinOne in the years ahead.”

To learn more about ClinOne and Adaptive Participant Experiences, visit http://www.clinone.com.

About ClinOne

ClinOne provides adaptive experiences for participants in clinical trials. By offering choice to patients, caregivers, and site staff, our technology makes it easier to stay active, compliant, and comfortable in a trial – thereby expanding enrollment access, reducing drop-out rate, and shortening conduct timelines. Our true single platform features solutions for local HCP trial awareness, remote and onsite eConsent, Uber Health, medication adherence, and a DCT portal. ClinOne stands alone with the industry’s fastest implementation (average 2-6 weeks), cost-efficient scale, and seamless API integrations for complex therapeutic areas such as Oncology, CNS, and Rare Disease in over 60 languages. To learn why more than 55 sponsors and CROs trust ClinOne in 100+ currently active studies to connect, inform, and empower participants to take control of their clinical trial experience, begin a conversation with our experts at http://www.clinone.com.

Share article on social media or email:

Leave a Reply